XIAMEN SINOPEG BIOTECH CO., LTD.

XIAMEN SINOPEG BIOTECH CO., LTD. is a dynamic science company specializing in drug delivery system (DDS) and new medical materials business. Established in 2011, the company boasts a high-level team with strong technical reserve focused on research, development, and production of high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients, ADC and ProTAC Linker, among others. Led by overseas returned doctors and foreign experts, SINOPEG has established strong cooperative relations with renowned universities and research institutes in China, including Xiamen University, Fudan University, and the Institute of Chemistry of Chinese Academy of Sciences. The company's commitment to technological development is evidenced by holding 32 IPs, 25 pending IPs, and 20 DMFs meeting FDA requirements, along with acquiring ISO13485 certification. Moreover, its laboratory and production workshop adhere to the cGMP standard of FDA and follow the requirements of ICH-Q7A to ensure the production of high-quality polyethylene glycol derivatives products and services on a global scale. SINOPEG's focus on cutting-edge solutions in the manufacturing industry positions it as a compelling prospect for potential investors seeking involvement in innovative medical materials and drug delivery systems.